Resmed Inc. buy Needham & Company LLC
Start price
24.06.24
/
50%
€178.55
Target price
24.06.25
€219.74
Performance (%)
24.28%
End price
25.06.25
€221.90
Summary
This prediction ended on 25.06.25 with a price of €221.90. The BUY prediction by Needham___Company_LL finished with a performance of 24.28%. A total of €1.48 was paid as dividends for this prediction. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | -4.317% | -4.317% | -2.742% |
| iShares Core DAX® | -0.975% | -4.716% | 4.787% |
| iShares Nasdaq 100 | 1.163% | 1.881% | 20.234% |
| iShares Nikkei 225® | -1.593% | -5.385% | 31.353% |
| iShares S&P 500 | -0.278% | 0.327% | 13.911% |
Comments by Needham___Company_LL for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $236.00 price target on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten